Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs. - Wikidata - awgldk - TriplyDB

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

http://www.wikidata.org/entity/Q30248914

about

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

http://www.wikidata.org/entity/Q30248914

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@ast

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@en

type

label

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@ast

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@en

prefLabel

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@ast

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@en

P1433

Q30248914-EE97B002-C453-4045-A712-29572E5DCA7B

P1476

Q30248914-97B308F2-3915-4133-B0DA-D7E27F226DD9

P2093

Q30248914-30564BBA-DAFC-4F07-A330-0C5B87037887

Q30248914-9496C80E-08E7-428B-AA6E-1592C2F2861A

Q30248914-C2B6FFF1-2F63-47D2-B191-1B2FB458DB43

Q30248914-CD197D7B-DE31-4033-BB43-BA9FD6A8FFF7

Q30248914-EE21FBC5-C1B8-4B3C-A79A-0ECE2BA6C907

Q30248914-F300D955-EB4E-4E80-AB78-9E4FC33D3B05

P2860

Q30248914-0275E59F-BD39-4E60-9DFC-178CE0EA9E83

Q30248914-044C2018-2DBE-4792-9864-A3F0FA827EC2

Q30248914-06FEF627-F3A5-4928-9040-887739B6667D

Q30248914-08BEEB0C-01C5-444C-A4F8-B6289669DB0D

Q30248914-096A3270-BC11-4055-9DE0-1C5C3A7B71D8

Q30248914-09EBC2F5-9087-43F9-B7D5-18C9317AB190

Q30248914-0AC97506-64EF-43EF-BE77-71923274BB53

Q30248914-0BC168C0-5D39-4DAD-93E2-121E5B8BE5EB

Q30248914-0C28B5A2-BDAF-4245-907F-31225FE1512D

Q30248914-141DE983-FC7C-4321-8CDE-6DE24DF99487

P2888

Q30248914-A0DE2288-742F-4105-B25E-347A63DC2E9A

P304

Q30248914-37C81EC4-DCEA-457B-915A-6866767F3268

P31

Q30248914-98DA2897-5568-4378-81E2-564668385CC1

P356

Q30248914-5AD71208-ECC9-43D0-A932-B34C3CDB33E3

P433

Q30248914-E20E6057-0C5C-480A-8479-4D943CAD96E0

P478

Q30248914-413A2708-1CF3-484E-A5B3-B62B978C8C0D

P50

Q30248914-3FF0FBE7-562A-4E52-A750-83493C8BB980

Q30248914-73354694-08F2-43C6-A049-63871409563E

Q30248914-FEAC3DC6-859E-4CCB-A423-80A53962F676

P577

Q30248914-31346620-9E25-41FD-87B3-B72720A0B997

P6179

Q30248914-74328E93-70F6-439F-A652-BB04739668C4

P698

Q30248914-53E5544D-7468-4DA8-986B-8873134227A3

P921

Q30248914-74557387-F324-4FB8-82C0-E8EE3B42C042

Q30248914-B37E8C68-4C0E-42B0-8916-4919763FBEF0

P356

P1433

The Pharmacogenomics Journal

P1476

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

@en

P2093

A L Birkenfeld

http://www.w3.org/2001/XMLSchema#string

D Hopkins

http://www.w3.org/2001/XMLSchema#string

D M Willmes

http://www.w3.org/2001/XMLSchema#string

F Pistrosch

http://www.w3.org/2001/XMLSchema#string

G Mingrone

http://www.w3.org/2001/XMLSchema#string

M A Daniels

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets

TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

The metabolic vascular syndrome - guide to an individualized treatment

P2888

P304

399-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TPJ.2016.54

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Stefan R. Bornstein

P577

2016-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029985382

http://www.w3.org/2001/XMLSchema#string

P698

27432533

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

type-2 diabetes